These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26846109)

  • 1. Low expression of PIDD is associated with cell proliferation and apoptosis in hepatocellular carcinoma.
    Shi W; Huang W; Chen Y; Zhang S; Xu P; Gu X; Fan H; Xu J; Chen Y; Ni R; Lu C; Zhang X
    Tumour Biol; 2016 Aug; 37(8):10447-57. PubMed ID: 26846109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High CHMP4B expression is associated with accelerated cell proliferation and resistance to doxorubicin in hepatocellular carcinoma.
    Hu B; Jiang D; Chen Y; Wei L; Zhang S; Zhao F; Ni R; Lu C; Wan C
    Tumour Biol; 2015 Apr; 36(4):2569-81. PubMed ID: 25874485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of vacuolar protein sorting 4B (VPS4B) is associated with accelerated cell proliferation and poor prognosis in human hepatocellular carcinoma.
    Jiang D; Hu B; Wei L; Xiong Y; Wang G; Ni T; Zong C; Ni R; Lu C
    Pathol Res Pract; 2015 Mar; 211(3):240-7. PubMed ID: 25547899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
    Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
    Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
    Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma.
    Huang W; Cui X; Chen Y; Shao M; Shao X; Shen Y; Liu Q; Wu M; Liu J; Ni W; Lu C; Wan C
    Pathol Res Pract; 2016 Mar; 212(3):171-8. PubMed ID: 26706601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
    Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma.
    Chen Y; Liu Q; Wu M; Li M; Ding H; Shan X; Liu J; Tao T; Ni R; Chen X
    Tumour Biol; 2016 Sep; 37(9):11763-11773. PubMed ID: 27026230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
    Huang X; Liu F; Zhu C; Cai J; Wang H; Wang X; He S; Liu C; Yao L; Ding Z; Zhang Y; Zhang T
    Dig Dis Sci; 2014 Apr; 59(4):795-806. PubMed ID: 24368420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Hu B; Xiong Y; Ni R; Wei L; Jiang D; Wang G; Wu D; Xu T; Zhao F; Zhu M; Wan C
    Mol Cell Biochem; 2014 Nov; 396(1-2):175-85. PubMed ID: 25081333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
    Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
    PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.
    Chang W; Yu Z; Tian M; Lin X
    Oncol Rep; 2017 Dec; 38(6):3489-3496. PubMed ID: 29130100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.